Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery. The addition of ExsoMed, whose products support an intermedullary approach to treating hand fractures, enhances Acumed's comprehensive portfolio of upper extremity solutions for simple to complex injuries.
HILLSBORO, Ore. , July 6, 2022 /PRNewswire-PRWeb/ -- Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery. The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed's comprehensive portfolio of upper extremity solutions for simple to complex injuries.
"Demand for minimally invasive surgical devices continues to grow and the ExsoMed products are great additions to our minimally invasive offerings," said Milton Torres , VP of Hand and Upper Extremity at Acumed. "ExsoMed's innovative products are a natural fit for Acumed's extensive portfolio of industry-first hand and wrist solutions. These products are designed to provide surgeons with in situ customization options to achieve optimal patient fit and restoration of function."
Acumed has the most complete selection of upper extremity fixation and specialty plates on the market* – now complemented by ExsoMed's threaded nails, which offer minimally invasive solutions to treat fractures, fusions, and late-stage arthritic conditions.
INnate™ – ExsoMed's revolutionary solution for treating metacarpal fractures. INnate™ is an intramedullary threaded nail designed to provide surgeons with a reliable solution for treating metacarpal fractures through a simple, minimally invasive approach.
InFrame™ – designed specifically for phalanx fractures, providing surgeons with a reliable solution through a simple, minimally invasive approach. The robust length offering of InFrame™ is intended to accurately fit the intramedullary canal and achieve bicortical bone purchase, creating stable fixation and precise reduction for all types of phalanx fractures.
ArrowPhix™ – ExsoMed's innovative arrow-shaped screw for functional variable angle DIP fusions. The related ArcPhix™ is an angled screw for strong, functional angle DIP fusions. Research has shown that when a patient's distal interphalangeal joint is fused in a functional position, finger dexterity and grip strength improve over that of a patient with a straight, strength fusion.1
"Patients, surgeons, and innovation have been the key drivers in all of ExsoMed's business decisions," said James Young Kim , Chief Marketing Officer for ExsoMed. "The culture, history, and ambitions of Acumed align so naturally for us at ExsoMed that this decision to join the growing Acumed family was never second-guessed. We are grateful for the opportunity to expand ExsoMed's technologies utilizing Acumed's vast resources and continuing to raise the standard of care in hand surgery."
"We are thrilled by the addition of ExsoMed to the extensive Acumed portfolio of innovative upper extremity, lower extremity, CMF, tendon, ligament, and orthobiologics solutions to better serve our customers worldwide," said Hjalmar Pompe van Meerdervoort, President of Acumed. "With Acumed's experience and vast resources, we are excited to combine efforts with ExsoMed to accelerate the shift in the standard of care for hand fractures."
Acumed serves highly skilled, specialized surgeons who demand comprehensive, high-quality medical devices for patients with simple to complex injuries for optimal restoration of function.
Acumed has more than three decades of experience in the orthopaedic industry, with the mission of aiding the afflicted through the ingenuity of our minds, the labor of our hands, and the compassion of our hearts. Acumed has three primary campuses in Hillsboro, Oregon ; Addison, Texas ; and Madrid, Spain , and offices around the world. OsteoMed is a wholly owned subsidiary of Acumed. For more information, visit http://www.acumed.net.
About ExsoMed Corporation ExsoMed is a medical device company providing orthopaedic surgeons with innovative solutions in hand surgery. We believe that our solutions raise the standard of care in hand surgery by providing state of the art surgical tools that streamline use in the operating room, reduce the global cost of care, and enhance outcomes so that patients can get back to life faster. ExsoMed is based in Aliso Viejo, California . For more information regarding ExsoMed, please visit http://www.exsomed.com.
About Colson Medical, LLC Chicago -based Colson Medical, LLC designs and manufactures specialty medical devices worldwide through its businesses: Acumed LLC, OsteoMed LLC, MicroAire Surgical Instruments LLC, Precision Edge Surgical Products Company LLC, and Apex (Guangzhou ) Tools & Orthopedics Co. These businesses offer innovative products used to help improve patient care and outcomes. They provide highly engineered implants such as plates, screws, and related precision tools, primarily for upper and lower extremity orthopedic, CMF, Neuro, and aesthetics surgeries. Together, they employ more than 1,300 people at locations in the U.S., China , the U.K., Spain , and Germany . Colson Medical, LLC is a subsidiary of Marmon Holdings, Inc., a Berkshire Hathaway company. For more information, visit https://www.colsonmedical.com.
1. Eitan Melamed , MD, Daniel B. Polatsch , MD, Steven Beldner , MD, Charles P. Melone, Jr. , MD Scientific Article. Simulated Distal Interphalangeal Joint Fusion of the Index and Middle Fingers in 0 and 20 degrees of Flexion: A Comparison of Grip Strength and Dexterity. J. Hand Surg Am. 2014; 39(10): 1986-1991.
*Competitive data on file with Acumed. GEN00-28-F; 2021.
Jamie Elmer , Senior Director, Global Brand and Communications, Acumed, 503-490-7906, jamie.elmer@acumed.net
Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.
Snap Inc. has never been an investor-friendly company as long as those investors weren't their founders, and the parent company of the Snapchat app made that even clearer Thursday.
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
Anthony Scaramucci, the short-lived White House communications director under Donald Trump, is a bitcoin evangelist.
Yahoo Finance Editor-in-Chief Andy Serwer discusses Berkshire's stake in Occidental Petroleum and what that indicates to investors.
Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.
Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.
U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.
Every one of those quarterly reports has shown a growing company, despite plenty of ups and downs in the economy—and the internet. Amazon’s worst quarter came in September 2001, when the internet bubble was blowing apart. Now, though, Amazon’s streak may be coming to an end.
Just where is the stock market going, that’s the question investors are trying to answer. The answer isn’t fully clear, though; markets have fallen for most of this year, but the last few days have seen the best trading in weeks. The problem is, investors and economists aren’t sure if we’re at a true bottom or just in the midst of a bear market rally. What happens next is anyone’s guess, but the history of bears and rallies can offer some suggestions. Looking back to the end of the Second World
The Dow Jones fought back. Tesla stock rocketed after Elon Musk gave an update on its "best product ever." Apple stock popped. Bitcoin fell.
Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
This money management maven doesn't mince words when it comes to what you shouldn’t be doing with your money.
(Bloomberg) -- Even for Alphabet Inc., financial gimmickry is no match for the power of the bear market.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla Purchasing ProbeBannon Found Guilty of Contempt for Defying Jan. 6 SubpoenaThe Google parent’s shares sank 2.5% on Monday, the first
Every investor – from the most experienced legends of Wall Street to the most amateur of retail traders – keeps a close eye on the market, looking for some sign or signal to indicate just the right trades. Following the corporate insiders is one way to find an advantage. These are the company officers whose positions put them ‘in-the-know’ on their companies’ inner workings. That knowledge gives these bigwigs an inside track when it comes to trading their own stocks – and to keep the trading flo
(Bloomberg) -- The housing market correction that’s taking hold in Canada could turn out to be its biggest in recent history, according to a new forecast from the country’s largest bank.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla Purchasing ProbeBannon Found Guilty of Contempt fo
Yahoo Finance markets reporter Alexandra Semenova details the surge in short interests on EV developer Tesla.
Everyone knows that chasing violent storms is risky for your life. But it turns out that yield chasing in the S&P 500 can be risky for your money.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla